Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study.

Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study.

One of the potential clinical uses of the new cerebral blood flow agent 99mTc-hexamethylpropyleneamineoxime (HM-PAO) is the investigation of dementia, in particular to differentiate between dementia of the Alzheimer type (DAT) and multiinfarct dementia (MID). In this study 27 patients, 17 with DAT a...

Full description

Bibliographic Details
Main Authors: Gemmell, H, Sharp, P, Besson, J, Crawford, JR, Ebmeier, K, Davidson, J, Smith, F
Format: Journal article
Language:English
Published: 1987

Similar Items

Similar Items